Every discussion about Net Asset Value (NAV) financing eventually becomes a discussion about time. The conversation often begins with Loan-To-Value (LTV), security, covenants, and documentation. But although those issues matter, they are rarely the whole story. Is the key question, does the market start in the wrong place?
Net Asset Value (NAV) is the value of an entity’s assets minus its liabilities. It is typically expressed on a per share basis to determine the value of mutual funds, exchange-traded funds (ETFs), or investment trusts.
Does additional time create additional value or simply defer a more difficult commercial decision? That question sits behind many NAV financings in today’s market. If additional time allows a sponsor to complete a value-creation plan, execute M&A, strengthen a portfolio company or run a more competitive exit process, a NAV facility may have a clear commercial purpose.
If additional time merely postpones an exit that remains uncertain, the analysis becomes very different. That distinction tends to shape everything that follows.
A market operating on longer timelines
Private equity is operating in a different environment from the one many managers expected a few years ago. Strong businesses continue to attract capital. Good sponsors continue to execute successful exits. But liquidity has become more selective, holding periods have generally extended, and Limited Partner (LP) conversations have become increasingly focused on Distributions to Paid-In Capital (DPI) alongside long-term value creation.
Against that backdrop, NAV financing has become part of a broader liquidity toolkit. Alongside Continuation Vehicles (CVs), preferred capital and other structured solutions, it allows sponsors to manage timing, preserve optionality and continue executing value-creation strategies without assuming that every portfolio company should be sold at the first available opportunity.
That does not make NAV financing inherently conservative or inherently aggressive. Like any financing tool, its merits depend on the circumstances in which it is being used.
The more interesting question is rarely whether a sponsor has chosen NAV financing, but why?
The product is rarely the issue
A common misconception is that NAV financing exists primarily because sponsors cannot sell assets. That is only part of the picture. Many facilities support entirely commercial objectives – funding acquisitions, financing growth initiatives, bridging to a defined exit process, or providing liquidity while allowing a portfolio company to continue executing its business plan.
Those situations can look very different from facilities where repayment depends largely on market conditions improving. The documents may appear similar, but the commercial rationale can be very different.
For me, that is why NAV transactions are rarely only about leverage. They are also a judgment about time. Is additional time likely to improve the outcome, or is it simply delaying a decision that the portfolio will still need to confront later?
Viewed through that lens, many of the debates around valuation, concentration, duration, and sponsor quality become different ways of assessing the same commercial question.
Where underwriting becomes more interesting
Much of the discussion around NAV financing still focuses on LTV. LTV matters. It is just not the whole picture.
In my experience, underwriting often turns on four broader questions:
Valuation
Not because lenders assume reported NAV is inaccurate, but because every advance rate depends on confidence that reported value can ultimately become realized value.
Concentration
A diversified portfolio presents a different credit proposition from one where repayment depends heavily on one or two assets. Headline LTV does not always capture that distinction.
Duration
Is there a clearly identifiable route to repayment, or does the repayment case depend primarily on exit conditions becoming more favorable?
Sponsor quality
Value creation and exit execution are related, but they are not the same skill. Experience navigating different market conditions can become increasingly relevant where timing is a significant part of the investment thesis.
None of these questions replaces LTV. Together, however, they often provide a more complete picture of the underlying credit.
Where continuation vehicles change the analysis
Some of the more technically interesting transactions today sit where NAV financing intersects with CVs. Commercially, the rationale can be compelling. A sponsor may wish to retain ownership of high-quality assets, provide liquidity to existing LPs, admit new investors and continue executing the value-creation plan.
From a financing perspective, that can create attractive opportunities. Structurally, however, the analysis becomes more involved. Valuation, LP elections, LPAC approvals, side letters, transfer restrictions, fund documentation, and financing mechanics all need to work together. The lender is no longer underwriting only a portfolio. The lender is also underwriting the structure through which that portfolio is held.
Why legal architecture still matters
One observation has become more consistent across these transactions. The legal questions are not usually difficult because the law is uncertain. More often, they arise because the fund documents were drafted years earlier, for a different purpose and without the current transaction in mind.
Borrowing powers. Side letters. Transfer provisions. Limited Partner Advisory Committee (LPAC) rights. Co-investment arrangements. Consent mechanics. None of those issues is unusual in isolation. The challenge is often how they interact once NAV financing is introduced.
By the time those questions emerge during documentation, commercial flexibility may already have narrowed. That is why the most useful conversations tend to happen before the first draft of the finance documents is circulated. The objective is not to make the transaction more complex. It is to identify structural issues early enough that they remain commercial decisions rather than legal constraints.
A market that continues to evolve
Sponsors, lenders, and investors continue to refine how these transactions are executed and structured. Market practice is developing alongside that evolution. That means there is rarely a single structure that suits every transaction. Some portfolios lend themselves to relatively straightforward senior NAV facilities. Others may be better suited to preferred capital, asset-level SPVs (standalone legal entities), CVs, or other bespoke structures.
The legal documentation is only one part of that process. Its purpose is to support a commercial strategy that has already been thought through carefully. It cannot substitute for one.
Conclusions
NAV financing is often discussed as though it were a product. I have found it more helpful to think of NAV financing as one financing approach within a broader liquidity toolkit.
Like any financing approach, it is not inherently conservative or inherently aggressive. Its suitability depends on the portfolio, the sponsor, the proposed use of proceeds and, ultimately, the credibility of the repayment story.
That remains the most interesting part of these transactions. Not the headline LTV. Not the pricing. Not even the structure itself. But the judgment.
Is additional time likely to create additional value, or is it more likely to defer a commercial decision that the portfolio will eventually need to address? That is part of what makes these transactions interesting to work on.
Good legal documentation can allocate risk. It can reinforce a well-considered commercial strategy. It is far less effective at correcting one that was never fully resolved. The documents matter. But ultimately, they matter because they reflect the quality of the commercial thinking that sits behind them.
Jason Blick is Of Counsel at law firm CMS.
